Here our VP of Technology Jonathan Eads breaks down how we used our Genomenon Genomic Graph (G3) to understand why colon cancer patients treated with immunotherapies exhibit a wide range of responses ranging from no effect to complete remission and if there are meaningful correlations.
Fill out this form to watch the recording.